Below is Validea's guru fundamental report for TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR) (TEVA). Of the 22 guru strategies we follow, TEVA rates highest using our Twin Momentum Investor model based ...

Carson Wentz could hold several AFC teams' playoff fates in his hands. With the No. 1 seed in the conference already secured, the Kansas City Chiefs will turn to their backup quarterback to start ...

Teva Pharmaceuticals CEO Richard Francis joins Seana Smith and Madison Mills on Catalysts to discuss what both the pharmaceutical company and industry at large are expecting from Trump's return to ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.